Drugs / 89-zr-dfo-star polyethylene glycol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06894745 | Jun 2025 → Dec 2027 expected | carcinoma, soft tissue neoplasm | University of California, San Francisco | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 89-zr-dfo-star polyethylene glycol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06894745 ↗ |
| Known as | StarPEG | “89-zr-dfo-star polyethylene glycol (StarPEG)” NCT06894745 ↗ |
| Modality | Diagnostic / imaging agent | “novel PET-imaging radiotracer” NCT06894745 ↗ |
| Route | Intravenous | “Given intravenously (IV)” NCT06894745 ↗ |